Susquehanna International Group, LLP Fulcrum Therapeutics, Inc. Call Options Transaction History

Susquehanna International Group, LLP

13 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$3.18 - $9.74 $1.35 Million - $4.15 Million	425,600 Added 324.14%	556,900 $1.99 Million
Q2 2024 Aug 15, 2024	SELL	$5.98 - $9.31 $1.04 Million - $1.62 Million	-174,200 Reduced 57.02%	131,300 $814,000
Q1 2024 May 07, 2024	BUY	$6.7 - $12.0 $10,050 - $18,000	1,500 Added 0.49%	305,500 $2.88 Million
Q4 2023 Feb 14, 2024	SELL	$3.18 - $6.86 $1,272 - $2,744	-400 Reduced 0.13%	304,000 $2.05 Million
Q3 2023 Nov 14, 2023	BUY	$3.25 - $6.08 $59,800 - $111,872	18,400 Added 6.43%	304,400 $1.35 Million
Q2 2023 Aug 11, 2023	SELL	$2.26 - $3.8 $27,119 - $45,600	-12,000 Reduced 4.03%	286,000 $943,000
Q1 2023 May 16, 2023	BUY	$2.83 - $13.99 $154,518 - $763,854	54,600 Added 22.43%	298,000 $849,000
Q4 2022 Feb 14, 2023	SELL	$5.01 - $8.35 $168,837 - $281,395	-33,700 Reduced 12.16%	243,400 $1.77 Million
Q3 2022 Nov 14, 2022	BUY	$4.92 - $9.1 $350,304 - $647,920	71,200 Added 34.58%	277,100 $2.24 Million
Q2 2022 Aug 15, 2022	BUY	$4.2 - $24.0 $488,040 - $2.79 Million	116,200 Added 129.54%	205,900 $1.01 Million
Q1 2022 May 16, 2022	BUY	$9.96 - $23.65 $432,264 - $1.03 Million	43,400 Added 93.74%	89,700 $2.12 Million
Q4 2021 Feb 14, 2022	SELL	$14.0 - $28.44 $131,600 - $267,336	-9,400 Reduced 16.88%	46,300 $819,000
Q3 2021 Nov 15, 2021	BUY	$7.28 - $30.97 $405,496 - $1.73 Million	55,700 New	55,700 $1.57 Million

150

52.2M

6.91M

1.9M

Ticker FULC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,038,900
Market Cap $226M
Description
Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.